期刊文献+

产后出血高危因素产妇预防性使用马来酸麦角新碱的临床疗效研究 被引量:13

Research on clinical effectiveness of ergometrine maleate on prevetion of postpartum hemorrhage for high-risk pregnant women
原文传递
导出
摘要 目的探讨马来酸麦角新碱注射液预防性使用对高危产妇产后出血的临床疗效和安全性。方法选取2018年6月-12月就诊于株洲市中心医院产后出血高危因素的产妇200例,按照胎儿娩出后和回病房时用药情况不同随机分为两组,对照组为单用缩宫素,观察组为缩宫素联合麦角新碱(分娩后缩宫素+麦角新碱,术后麦角新碱)。比较各组术中及产后2、4、12、24 h出血量,额外产后出血止血措施的使用率及用药后产妇血压的变化情况。结果观察组术中出血量及产后12、24 h出血增量分别为(337.0±148.1)、(75.8±16.8)、(116.4±20.3) mL,明显低于对照组数据(281.6±100.7)、(69.9±17.2)、(107.9±17.2)mL,差异有统计学意义(P<0.05)。比较两组使用其他宫缩剂及止血措施,观察组明显低于对照组,差异具有统计学意义(P<0.05)。结论预防性使用马来酸麦角新碱可明显减少产妇产后出血发生率和出血量,加强子宫收缩安全有效,值得临床推广和应用。 Objective To investigate the clinical efficacy and safety of preventive use of for the postpartum hemorrhage in high-risk pregnant women.Methods 200 patients with high-risk of postpartum hemorrhage in our hospital from June to December 2018 were selected as the research subjects.Patients were divided into two groups according to the different situation of medication after delivery of the fetus and on the way back to the ward.The patients in the control group were treated with oxytocin alone,while in the study group,oxytocin combined with ergometrine was used(oxytocin + ergometrine after childbirth,and ergosine after surgery).The bleeding volume and side effects of the operation,2 h,4 h,12 h,and 24 h after operation were analyzed and compared.Analysis of variance or Chi-square test was used for statistical analysis.Results In the study group,the amount of blood loss of the operation,12 h,and 24 h after operation were(337.0±148.1) mL,(75.8±16.8) mL,(116.4±20.3) mL,respectively,which were significantly less than those in control group(281.6±100.7) mL,(69.9±17.2) mL,(107.9±17.2) mL(The patients in the control group were treated with oxytocin alone,while in the study group,oxytocin combined with ergometrine was used(oxytocin + ergometrine after childbirth,and ergosine after surgery).The bleeding volume and side effects of the operation,2 h,4 h,12 h,and 24 h after operation were analyzed and compared.Analysis of variance or Chi-square test was used for statistical analysis.Results In the study group,the amount of blood loss of the operation,12 h,and 24 h after operation were(337.0±148.1) mL,(75.8±16.8) mL,(116.4±20.3) mL,respectively,which were significantly less than those in control group(281.6±100.7) mL,(69.9±17.2) mL,(107.9±17.2) mL(P<0.05).Compare two groups using other contractions and bleeding,the study group significantly lower than the control group,the difference is statistically significant(P<0.05).Conclusion Preventive use of ergotamine maleate can significantly reduce the incidence and amount of postpartum hemorrhage,strengthen uterine contractions safe and effective,worthy of clinical promotion and application.
作者 曾范华 谢恺俐 柒铭铭 王芳 黄荣 刘小利 ZENG Fanhua;XIE Kaili;QI Mingming;WANG Fang;HUANG Rong;LIU Xiaoli(Department of Obstetrics, Zhuzhou Central Hospital, Zhuzhou 412007, China)
出处 《药物评价研究》 CAS 2019年第7期1383-1386,共4页 Drug Evaluation Research
关键词 产后出血 预防性 马来酸麦角新碱 疗效 postpartum hemorrhage preventive ergometrine maleate efficacy discussion
  • 相关文献

参考文献6

二级参考文献92

  • 1Nan Schuurmans MD,FRCSC, Edmonton AB,Catherine MacKinnon MD,FRCSC, Brantford,ON Carolyn Lane MD,CCFP Calgary,AB Duncan Etches MD,CCFP Vancouver BC,刘铭(译),段涛(译).产后出血的预防和处理指南[J].现代妇产科进展,2007,16(3):175-185. 被引量:152
  • 2Fonseca L, Wood HC, Lucas M J, et al. Randomized trial of preinduction cervical ripening: misoprostol vs oxytocin [J]. Am J Obstet Gynecol,2008,199 ( 3 ) : 305. e1 -5.
  • 3Alfirevic Z, Kelly A J, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour[ J]. Cochrane Database Syst Rev,2009, (4) :CD003246.
  • 4ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 107 : Induction of labor [ J ]. Obstet Gynectol, 2009,114(2 Pt 1 ) :386-397.
  • 5Society of Obstetricians and Gynaecologists of Canada. SOCG Clinical Practice Guideline. Induction of labour at term [ J ]. J Obstet Gynaecol Can ,2001,23 ( 8 ) :717-728.
  • 6Cunningham FG. Williams obstetrics[ M]. 23rd ed. New York (NY) : McGraw-Hill, 2010 : Chap 22.
  • 7Wen T, Beceir A, Xenakis E, et al. Is there a maximum effective dose of Pitocin? [ J ]. Am J Obstet Gynecol, 2001,185 : S212.
  • 8Hayes EJ, Weinstein L. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin [J]. Am J Obstet Gyneco!,2008,198:622. e1-622.
  • 9Girard B, Vardon D, Creveuil C, et al. Discontinuation of oxytocin in the active phase of labor [ J ]. Acta Obstet Gynecol Scand ,2009,88 ( 2 ) : 172-177.
  • 10Clark SL, Simpson KR, Knox GE, et al. Oxytocin: new perspectives on an old drug[M]. Am J Obstet Gynecol,2009,200: 35.

共引文献1055

同被引文献74

引证文献13

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部